west china medical publishers
Author
  • Title
  • Author
  • Keyword
  • Abstract
Advance search
Advance search

Search

find Author "MENG Hong" 2 results
  • Expression of CRABPⅡ, E-FABP and Ki67 in Breast Invasive Ductal Carcinoma and Their Correlation

    目的 研究细胞视黄酸结合蛋白(CRABP)Ⅱ、表皮型脂肪酸结合蛋白(E-FABP)和Ki-67在乳腺浸润性导管癌中的表达情况及三者的相关性。 方法 采用免疫组织化学检测2001年1月-2007年12月手术切除的152例乳腺浸润性导管癌中CRABPⅡ、E-FABP和Ki-67的表达。 结果 在浸润性导管癌中,CRABPⅡ在Ki-67阴性组的阳性率高于Ki-67阳性组(P<0.05),相反地,E-FABP在Ki-67阳性组的阳性率高于Ki-67阴性组(P<0.05)。CRABPⅡ和Ki-67表达呈负相关(rS=?0.432,P<0.05);E-FABP和Ki-67表达呈正相关(rS=0.842, P<0.05)。E-FABP和Ki-67的表达具有协同性,E-FABP和Ki-67共同表达与肿瘤的转移有关(P<0.05)。单因素生存分析显示,E-FABP的阳性表达患者、Ki-67的阳性表达患者以及E-FABP和Ki-67的共同阳性表达患者的预后差(P<0.05)。多因素生存分析提示E-FABP的表达(RR=4.223,P=0.012)和TNM分期(RR=8.412,P=0.000)是影响浸润性导管癌患者预后的独立危险因素。 结论 在乳腺浸润性导管癌中,CRABPⅡ和E-FABP与肿瘤细胞的增殖有关,CRABPⅡ抑制细胞增殖,E-FABP促进细胞增殖。E-FABP和Ki-67在浸润性导管癌的发生、发展中起协同作用,两者的阳性表达可能对评估肿瘤的转移和患者的预后有一定价值。

    Release date:2016-09-07 02:38 Export PDF Favorites Scan
  • Comparison of two approaches for newborn with critical congenital heart disease

    ObjectiveTo summarize our experience of critical congenital heart diseases treatment system for the newborn and to report its surgical results.MethodsWe reviewed the clinical data of 97 neonates with congenital heart diseases who admitted to pediatric cardiac center from January 2019 to August 2020 in our hospital. The patients were divided into a prenatal and postnatal diagnosis and treatment integration group (integrated group, n=41), and a postnatal diagnosis and rapid admission by green channel group (non-integrated group, n=56).ResultsThe age of admission in the integrated group was younger than that in the non-integrated group (3.0 d vs. 11.0 d, P<0.001), and the weight was lighter (3.3±0.4 kg vs. 3.6±0.6 kg, P=0.006), operation age was younger (13.0 d vs. 17.5 d, P=0.004), proportion of palliative surgery was smaller (2.4% vs. 8.9%, P=0.396), time for ventilator assistance was longer (153.0 h vs. 65.0 h, P=0.020), hospital mortality was lower (0.0% vs. 7.1%, P=0.135). There was no significant difference in the follow-up (11.0 months vs. 12 months, P=1.000), out-of-hospital mortality (2.4% vs. 1.8%, P=1.000) and total mortality (2.4% vs. 8.9%, P=0.396) between the two groups.ConclusionPrenatal and postnatal diagnosis and treatment integration can significantly shorten the diagnosis and the hospitalization interval of newborn, that surgical intervention could be performed timely. It can reduce the risk of death before surgery but need longer time for recovery after surgery. Patients with postnatal diagnosis and admitted hospital through green channel also can get perfect results if surgical intervention is performed timely.

    Release date:2020-12-30 02:01 Export PDF Favorites Scan
1 pages Previous 1 Next

Format

Content